Reduced Rate of Inpatient Hospital Admissions in 18 German University Hospitals During the COVID-19 Lockdown.


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2020
Historique:
received: 12 08 2020
accepted: 11 12 2020
entrez: 1 2 2021
pubmed: 2 2 2021
medline: 13 2 2021
Statut: epublish

Résumé

The COVID-19 pandemic has caused strains on health systems worldwide disrupting routine hospital services for all non-COVID patients. Within this retrospective study, we analyzed inpatient hospital admissions across 18 German university hospitals during the 2020 lockdown period compared to 2018. Patients admitted to hospital between January 1 and May 31, 2020 and the corresponding periods in 2018 and 2019 were included in this study. Data derived from electronic health records were collected and analyzed using the data integration center infrastructure implemented in the university hospitals that are part of the four consortia funded by the German Medical Informatics Initiative. Admissions were grouped and counted by ICD 10 chapters and specific reasons for treatment at each site. Pooled aggregated data were centrally analyzed with descriptive statistics to compare absolute and relative differences between time periods of different years. The results illustrate how care process adoptions depended on the COVID-19 epidemiological situation and the criticality of the disease. Overall inpatient hospital admissions decreased by 35% in weeks 1 to 4 and by 30.3% in weeks 5 to 8 after the lockdown announcement compared to 2018. Even hospital admissions for critical care conditions such as malignant cancer treatments were reduced. We also noted a high reduction of emergency admissions such as myocardial infarction (38.7%), whereas the reduction in stroke admissions was smaller (19.6%). In contrast, we observed a considerable reduction in admissions for non-critical clinical situations, such as hysterectomies for benign tumors (78.8%) and hip replacements due to arthrosis (82.4%). In summary, our study shows that the university hospital admission rates in Germany were substantially reduced following the national COVID-19 lockdown. These included critical care or emergency conditions in which deferral is expected to impair clinical outcomes. Future studies are needed to delineate how appropriate medical care of critically ill patients can be maintained during a pandemic.

Identifiants

pubmed: 33520914
doi: 10.3389/fpubh.2020.594117
pmc: PMC7838458
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

594117

Informations de copyright

Copyright © 2021 Kapsner, Kampf, Seuchter, Gruendner, Gulden, Mate, Mang, Schüttler, Deppenwiese, Krause, Zöller, Balig, Fuchs, Fischer, Haverkamp, Holderried, Mayer, Stenzhorn, Stolnicu, Storck, Storf, Zohner, Kohlbacher, Strzelczyk, Schüttler, Acker, Boeker, Kaisers, Kestler and Prokosch.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Methods Inf Med. 2018 Jul;57(S 01):e50-e56
pubmed: 30016818
Eur Heart J. 2020 May 14;41(19):1852-1853
pubmed: 32297932
Appl Clin Inform. 2011 Mar 30;2(1):116-27
pubmed: 23616864
BMC Med Inform Decis Mak. 2020 Dec 21;20(1):341
pubmed: 33349259
Eur Neurol. 2020;83(2):213-215
pubmed: 32289789
Stroke. 2020 Jul;51(7):2224-2227
pubmed: 32516064
JCO Clin Cancer Inform. 2020 Jul;4:657-665
pubmed: 32716647
Br J Surg. 2020 Oct;107(11):1440-1449
pubmed: 32395848
J Am Med Inform Assoc. 2010 Mar-Apr;17(2):124-30
pubmed: 20190053
Stud Health Technol Inform. 2019 Sep 3;267:247-253
pubmed: 31483279
Methods Inf Med. 2018 Jul;57(S 01):e66-e81
pubmed: 30016813
Clin Neuroradiol. 2018 Jun;28(2):225-234
pubmed: 29313057
Methods Inf Med. 2018 Jul;57(S 01):e82-e91
pubmed: 30016814
Acta Biomed. 2020 May 11;91(2):89-96
pubmed: 32420932
Dtsch Arztebl Int. 2020 Jul 6;117(27-28):488-489
pubmed: 33050998
AMIA Annu Symp Proc. 2007 Oct 11;:548-52
pubmed: 18693896
J Am Coll Cardiol. 2020 Jun 9;75(22):2871-2872
pubmed: 32283124
N Engl J Med. 2020 Jul 23;383(4):400-401
pubmed: 32383831
G Ital Cardiol (Rome). 2020 Jul;21(7):502-508
pubmed: 32555565
Methods Inf Med. 2018 Jul;57(S 01):e57-e65
pubmed: 30016812
Clin Res Cardiol. 2020 Dec;109(12):1476-1482
pubmed: 32494921
Int Orthop. 2020 Aug;44(8):1473-1480
pubmed: 32451655
Methods Inf Med. 2018 Jul;57(S 01):e92-e105
pubmed: 30016815

Auteurs

Lorenz A Kapsner (LA)

Medical Center for Information and Communication Technology, Universitätsklinikum Erlangen, Erlangen, Germany.
Department of Radiology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Marvin O Kampf (MO)

Medical Center for Information and Communication Technology, Universitätsklinikum Erlangen, Erlangen, Germany.

Susanne A Seuchter (SA)

Medical Center for Information and Communication Technology, Universitätsklinikum Erlangen, Erlangen, Germany.

Julian Gruendner (J)

Chair of Medical Informatics, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Christian Gulden (C)

Chair of Medical Informatics, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Sebastian Mate (S)

Medical Center for Information and Communication Technology, Universitätsklinikum Erlangen, Erlangen, Germany.

Jonathan M Mang (JM)

Medical Center for Information and Communication Technology, Universitätsklinikum Erlangen, Erlangen, Germany.

Christina Schüttler (C)

Chair of Medical Informatics, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Noemi Deppenwiese (N)

Chair of Medical Informatics, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Linda Krause (L)

Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Daniela Zöller (D)

Institute of Medical Biometry and Statistics, Medical Faculty and Medical Center, University of Freiburg, Freiburg, Germany.

Julien Balig (J)

Institute of Medical Systems Biology, Ulm University, Ulm, Germany.

Timo Fuchs (T)

Department of Nuclear Medicine, University Hospital Regensburg, Regensburg, Germany.

Patrick Fischer (P)

Institute of Medical Informatics, Faculty of Medicine, Justus-Liebig-University, Gießen, Germany.

Christian Haverkamp (C)

Institute of Digitalisation in Medicine, Medical Faculty and Medical Center, University of Freiburg, Freiburg, Germany.

Martin Holderried (M)

Department of Medical Development and Quality Management, University Hospital Tübingen, Tübingen, Germany.

Gerhard Mayer (G)

Institute of Medical Systems Biology, Ulm University, Ulm, Germany.

Holger Stenzhorn (H)

Saarland University Medical Center, Institute for Medical Biometry, Epidemiology and Medical Informatics, Homburg, Germany.
Institute for Translational Bioinformatics, University Hospital Tübingen, Tübingen, Germany.

Ana Stolnicu (A)

Institute of Medical Systems Biology, Ulm University, Ulm, Germany.

Michael Storck (M)

Institute of Medical Informatics, University of Münster, Münster, Germany.

Holger Storf (H)

Medical Informatics Group, Universitätsklinikum Frankfurt, Frankfurt, Germany.

Jochen Zohner (J)

Institute of Medical Informatics, Faculty of Medicine, Justus-Liebig-University, Gießen, Germany.

Oliver Kohlbacher (O)

Institute for Translational Bioinformatics, University Hospital Tübingen, Tübingen, Germany.
Applied Bioinformatics, Department of Computer Science, University of Tübingen, Tübingen, Germany.
Institute for Bioinformatics and Medical Informatics, University of Tübingen, Tübingen, Germany.
Biomolecular Interactions, Max Planck Institute for Developmental Biology, Tübingen, Germany.

Adam Strzelczyk (A)

Epilepsy Center Frankfurt Rhine-Main, Center of Neurology and Neurosurgery, Goethe University Frankfurt, Frankfurt, Germany.

Jürgen Schüttler (J)

Department of Anesthesiology, University Hospital Erlangen, Erlangen, Germany.

Till Acker (T)

Institute of Neuropathology, Justus-Liebig-University, Gießen, Germany.

Martin Boeker (M)

Institute of Medical Biometry and Statistics, Medical Faculty and Medical Center, University of Freiburg, Freiburg, Germany.

Udo X Kaisers (UX)

Ulm University Medical Center, Ulm, Germany.

Hans A Kestler (HA)

Institute of Medical Systems Biology, Ulm University, Ulm, Germany.

Hans-Ulrich Prokosch (HU)

Chair of Medical Informatics, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH